Chorionic gonadotropin pre-coated ELISA plate, preparation method thereof, method for quantitatively detecting HCG in human urine and kit
By preparing a stable pre-coated ELISA plate for human chorionic gonadotropin (hCG), and combining it with fluorescent magnetic microparticle ELISA and double-antibody sandwich ELISA, the issues of quantification, sensitivity, stability, and cost in hCG detection have been resolved. This enables rapid, low-cost, large-scale hCG detection with significant medical applications.
Patent Information
- Application Number
- CN202011157485.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2020-10-26
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2040-10-26
AI Technical Summary
Existing HCG detection methods suffer from problems such as inability to quantify, low sensitivity, poor stability, limited detection range, low repeatability, insufficient accuracy, high cost, and inability to perform large-scale detection.
A method for preparing ELISA plates pre-coated with human chorionic gonadotropin (hCG) was adopted, combined with fluorescent magnetic microparticle ELISA and double-antibody sandwich ELISA, to prepare ELISA plates with good stability. The hCG content in human urine was detected by standard curve.
It enables rapid, low-cost, large-scale, highly sensitive, accurate, and reproducible quantitative detection of HCG, suitable for diagnosis, monitoring, and treatment in the medical and health sector.
Smart Images

Figure BDA0002743198180000201 
Figure BDA0002743198180000211 
Figure BDA0002743198180000212
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of enzyme-linked immunosorbent assay, and in particular to a chorionic gonadotropin pre-coated ELISA plate, a preparation method thereof, a method for quantitatively detecting HCG in human urine, and a kit. Background Art
[0002] HCG quantitative detection is an important part of the production of this drug by many biopharmaceutical companies. The current technologies for detecting HCG in urine include colloidal gold method, enzyme-linked immunosorbent assay, radioimmunoassay, chemiluminescence immunoassay, fluorescent magnetic microparticle enzyme-linked immunosorbent assay and time-resolved fluorescent immunoassay. However, the commonly used methods for pharmaceutical companies are colloidal gold method, enzyme-linked immunosorbent assay and fluorescent magnetic microparticle enzyme-linked immunosorbent assay (Fully Automatic Fluorescent Magnetic Microparticle ELISA AIA-360 of Tosoh Corporation, Japan): Colloidal gold method can detect a large number of samples quickly and at low cost, but it cannot be quantitative, has low sensitivity, poor stability, limited detection range and low repeatability; enzyme-linked immunosorbent assay can detect quickly and on a large scale at low cost, but it is not accurate enough and has deviations; fluorescent magnetic microparticle enzyme-linked immunosorbent assay has high accuracy and repeatability, but the equipment and consumables cost is high, and it cannot be tested on a large scale.
[0003] In view of this, the present invention is proposed. Summary of the invention
[0004] The object of the present invention is to provide a method for preparing a chorionic gonadotropin pre-coated ELISA plate, which can prepare a chorionic gonadotropin pre-coated ELISA plate with good stability and long shelf life in large quantities, is convenient for subsequent experiments and detection, greatly saves time and operating costs, and improves analysis efficiency.
[0005] The purpose of the present invention is to provide a method for quantitatively detecting HCG in human urine, which can perform large-scale detection of the content of HCG in urine, is rapid and low in cost, and has high sensitivity, accuracy and repeatability.
[0006] The object of the present invention is to provide a kit for quantitatively detecting HCG in human urine, which comprises various reagents involved in the method of the present application, thereby simplifying the quantitative detection of HCG in human urine.
[0007] The present invention is achieved in that:
[0008] In a first aspect, an embodiment of the present invention provides a method for preparing a chorionic gonadotropin pre-coated ELISA plate, comprising:
[0009] The ELISA plate with HCG monoclonal antibody was incubated at 2-8°C for 8-12 hours, and then incubated at 36-38°C for 1-2 hours. The ELISA plate was then washed with a washing solution, and a blocking solution was added for blocking and incubated at 36-38°C for 1-2 hours. The blocking solution in the ELISA plate was then removed.
[0010] Wherein, the concentration of HCG antibody in the HCG monoclonal antibody is 2-3 μg / ml.
[0011] In an optional embodiment, the HCG monoclonal antibody is obtained by diluting the HCG antibody with a coating buffer;
[0012] Preferably, the coating buffer is a mixed aqueous solution containing anhydrous disodium hydrogen phosphate, sodium chloride, potassium chloride, potassium dihydrogen phosphate and a preservative; wherein the concentration of anhydrous disodium hydrogen phosphate in the coating buffer is 1-2 g / L, the concentration of sodium chloride is 7.5-8.5 g / L, the concentration of potassium chloride is 0.1-0.3 g / L, the concentration of potassium dihydrogen phosphate is 0.2-0.3 g / L and the concentration of the preservative is 0.4-0.6 ml / L.
[0013] In an optional embodiment, the blocking solution is prepared by mixing sucrose, bovine serum albumin and a blocking buffer, wherein the concentration of the sucrose is 8-12 g / ml, and the concentration of the bovine serum albumin is 0.4-0.6 g / ml;
[0014] The blocking buffer is a mixed aqueous solution of anhydrous disodium hydrogen phosphate, sodium dihydrogen phosphate dihydrate and a preservative, wherein the concentration of the anhydrous disodium hydrogen phosphate in the blocking buffer is 5-6 g / L, the concentration of sodium dihydrogen phosphate dihydrate is 1-2 g / L, and the concentration of the preservative is 0.4-0.6 ml / L.
[0015] In an optional embodiment, removing the blocking solution from the ELISA plate comprises: first turning the ELISA plate upside down to allow the blocking solution to drain out, and then drying the ELISA plate at 36-38° C. for 2-3 hours;
[0016] Preferably, after drying the ELISA plate, the method further comprises packaging and storing the ELISA plate: wrapping each of the dried ELISA plates together with 2-3 bags of desiccant with 4-6 layers of plastic wrap, and then storing at 2-8°C for 1 month or below -10°C for 6 months.
[0017] In an optional embodiment, drying the ELISA plate comprises: drying at 36-38° C. for 2-3 hours.
[0018] In a second aspect, an embodiment of the present invention provides a chorionic gonadotropin pre-coated ELISA plate, which is prepared by the preparation method of the chorionic gonadotropin pre-coated ELISA plate described in any one of the aforementioned embodiments.
[0019] In a third aspect, an embodiment of the present invention provides a method for quantitatively detecting HCG in human urine, comprising: using the chorionic gonadotropin pre-coated ELISA plate as described in any of the above embodiments for analysis;
[0020] Preferably, HCG antibody diluent labeled with HRP is added to the chorionic gonadotropin pre-coated ELISA plate prepared by the preparation method of the chorionic gonadotropin pre-coated ELISA plate;
[0021] Adding HCG standard solutions with different concentrations and urine sample dilution solutions with different concentrations to the chorionic gonadotropin pre-coated ELISA plate for incubation, plate washing, color development and termination, and then measuring the absorbance value;
[0022] Then the reading results are processed: the reading results are sorted from small to large according to the OD value, and 6 urine samples with gradient OD values are selected to detect the immunological titer of HCG by fluorescent magnetic particle enzyme-linked immunosorbent analyzer, and then a standard curve is made with the OD value of the urine sample as the horizontal axis and the immunological titer as the vertical axis, and the curve equation is calculated;
[0023] The HRP-labeled HCG antibody diluent is prepared by diluting the HRP-labeled HCG antibody solution with the labeled antibody diluent at a ratio of 1:1400-1600; the concentration of the urine sample in the urine sample diluent is 8-12 μl / ml.
[0024] In an optional embodiment, the HCG standard solution is obtained by diluting the HCG standard to different concentration gradients, wherein the HCG standard is diluted with a product of known potency to form a solution with an HCG potency of 9000-11000mIU / ml.
[0025] In an optional embodiment, a colorant with a concentration of 1-3‰ is also added to the urine sample diluent;
[0026] Preferably, the colorant is a blue food colorant.
[0027] In an optional embodiment, developing the color of the ELISA plate comprises: adding a color developing solution to the ELISA plate and incubating at 36-38° C. for 10-15 min;
[0028] Preferably, the color developing solution comprises 0.4-0.6 ml of substrate solution A, 9.4-9.6 ml of substrate solution B, and 40-45 μl of substrate solution C;
[0029] Wherein, the substrate solution A is a mixed solution of 3,3,5,5-tetramethylbenzidine and anhydrous ethanol, wherein the concentration of the 3,3,5,5-tetramethylbenzidine is 1-3 mg / ml;
[0030] The substrate solution B is a mixed aqueous solution of anhydrous disodium hydrogen phosphate and citric acid, wherein the concentration of anhydrous disodium hydrogen phosphate in the substrate solution B is 7-8 g / L, and the concentration of citric acid is 4-6 g / L;
[0031] The substrate solution C is an aqueous solution in which H2O2 with a volume concentration of 25-35% and water is diluted in a ratio of 1:35-45.
[0032] A fourth method, an embodiment of the present invention provides a kit for quantitatively detecting HCG in human urine, comprising a chorionic gonadotropin pre-coated ELISA plate as described in any one of the aforementioned embodiments;
[0033] Preferably, the kit further comprises HRP-labeled HCG antibody, washing solution, color developing solution and stop solution.
[0034] The present invention has the following beneficial effects:
[0035] The preparation method of the chorionic gonadotropin pre-coated ELISA plate provided by the present application can prepare a chorionic gonadotropin pre-coated ELISA plate with a long shelf life and stable product. By making a large number of chorionic gonadotropin pre-coated ELISA plates at one time, it is convenient for subsequent experiments and detection, greatly saving time and operating costs, and improving analysis efficiency. Due to the low titer of chorionic gonadotropin in urine, the chorionic gonadotropin pre-coated ELISA plate provided by the present application can be detected in the case of low HCG antibody concentration (2-3μg / ml), proving that the chorionic gonadotropin pre-coated ELISA plate of the present application has high sensitivity. Further, the method for quantitatively detecting HCG in human urine provided by the present application combines the fluorescent magnetic particle enzyme-linked immunosorbent assay method and the double antibody sandwich enzyme-linked immunosorbent assay method, which solves the problems of inability to quantify, low sensitivity, poor stability, limited detection range and low repeatability relative to the colloidal gold method; solves the problems of insufficient accuracy and deviation relative to the single enzyme-linked immunosorbent assay; solves the problems of high cost and inability to detect on a large scale relative to the single fluorescent magnetic particle enzyme-linked immunosorbent assay and other cutting-edge detection technologies; Based on the above, the method provided by the present application can detect the content of HCG in urine on a large scale, which is fast and low cost (taking 96 plates as an example, the average cost per well is about 0.434 yuan), with high sensitivity, accuracy and repeatability. The advantages are very obvious. In addition, it is of great significance to many medical and health departments in diagnosing, monitoring and treating various diseases of the human body. The kit for quantitatively detecting HCG in human urine provided by the present application includes various reagents involved in the method of the present application, thereby simplifying the quantitative detection of HCG in human urine. DETAILED DESCRIPTION
[0036] In order to make the purpose, technical scheme and advantages of the embodiments of the present invention clearer, the technical scheme in the embodiments of the present invention will be described clearly and completely below. If the specific conditions are not specified in the embodiments, they are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.
[0037] The present application provides a chorionic gonadotropin pre-coated ELISA plate, a preparation method thereof, a method for quantitatively detecting HCG in human urine, and a kit.
[0038] The preparation method of the chorionic gonadotropin pre-coated ELISA plate includes: keeping the ELISA plate with HCG monoclonal antibody at 2-8°C for 8-12 hours, then incubating at 36-38°C for 1-2 hours, then washing the incubated ELISA plate with a washing solution, adding a blocking solution for blocking and incubating at 36-38°C for 1-2 hours, and then removing the blocking solution from the ELISA plate; wherein the concentration of HCG antibody in the HCG monoclonal antibody is 2-3μg / ml.
[0039] Specifically, the method for preparing the chorionic gonadotropin pre-coated ELISA plate comprises the following steps:
[0040] S101, reagent preparation
[0041] HCG coated antibody packaging: After the newly purchased HCG antibody (ABBEST; Anti-h HCG McAb, Zhengzhou Baiman Biotechnology Co., Ltd., product number 031047001) is melted at room temperature, the packaging volume is calculated according to its labeled concentration of 240μg / tube (8 ELISA plates / tube), and the packaging is carried out. After packaging, mark it, store it below -10℃, and use it within the validity period.
[0042] Coating buffer : The coating buffer is a mixed aqueous solution containing anhydrous disodium hydrogen phosphate, sodium chloride, potassium chloride, potassium dihydrogen phosphate and a preservative; wherein the concentration of anhydrous disodium hydrogen phosphate in the coating buffer is 1-2g / L, the concentration of sodium chloride is 7.5-8.5g / L, the concentration of potassium chloride is 0.1-0.3g / L, the concentration of potassium dihydrogen phosphate is 0.2-0.3g / L and the concentration of the preservative is 0.4-0.6ml / L.
[0043] As a typical but non-limiting example, the coating buffer is prepared as follows: accurately weigh 1.44 g of anhydrous disodium hydrogen phosphate, 7.9 g of sodium chloride, 0.2 g of potassium chloride, and 0.24 g of potassium dihydrogen phosphate, add 800 ml of purified water, stir until completely dissolved, add 0.5 ml of proclin 300 preservative (Shanjing Biological, product number: ZB116) (concentration 0.05%), make up to 1000 ml, shake well, and store at 2-8°C. The shelf life is 1 month.
[0044] Blocking buffer : It is a mixed aqueous solution of anhydrous disodium hydrogen phosphate, sodium dihydrogen phosphate dihydrate and a preservative, wherein the concentration of anhydrous disodium hydrogen phosphate in the blocking buffer is 5-6g / L, the concentration of sodium dihydrogen phosphate dihydrate is 1-2g / L, and the concentration of the preservative is 0.4-0.6ml / L.
[0045] As a typical but non-limiting example, the preparation method of the blocking buffer is: accurately weigh 5.75 g of anhydrous disodium hydrogen phosphate and 1.3 g of sodium dihydrogen phosphate dihydrate, add 800 ml of purified water, stir until completely dissolved, add 0.5 ml of proclin 300 preservative (Shanjing Biological, product number: ZB116) (concentration 0.05%), make up to 1000 ml, shake well, and store at 2-8°C. The shelf life is 1 month.
[0046] Blocking solution: It is prepared by mixing sucrose, bovine serum albumin and blocking buffer, wherein the concentration of sucrose is 8-12g / ml and the concentration of bovine serum albumin is 0.4-0.6g / ml.
[0047] As a typical but non-limiting example, the preparation method of the blocking solution is: accurately weigh 30 g of sucrose (concentration 10%), 1.5 g of bovine serum albumin (BSA) (concentration 0.5%), add 300 ml of blocking buffer, stir until completely dissolved, and the solution is ready for immediate use.
[0048] Phosphate buffer stock solution (10×PBS): As a typical but non-limiting example, accurately weigh 14.38 g of anhydrous disodium hydrogen phosphate, 79 g of sodium chloride, 2 g of potassium chloride, and 2.4 g of potassium dihydrogen phosphate, add 800 ml of purified water, stir until completely dissolved, make up to 1000 ml, shake well, and store at room temperature. The shelf life is 3 days.
[0049] Washing liquid (PBST): As a typical but non-limiting example, measure 400 ml of phosphate buffer stock solution, 3600 ml of purified water, and 4 ml of Tween-20 (0.1%), mix and stir evenly, and the mixture is ready for immediate use.
[0050] It should be understood that the dosage of the above reagents can be changed according to the above ratios or adjusted within a certain range.
[0051] S102, Preparation of pre-coated ELISA plates
[0052] Preparation: Take 16 new ELISA plates (high-absorption transparent ELISA plates, Wuxi Guosheng Bioengineering Co., Ltd., CIH-F8T), mark each one (category, date and number), and keep them for later use;
[0053] Dilute HCG monoclonal antibody: Take 10 ml of coating buffer for each ELISA plate (16 plates require a total of 160 ml) and add it to a beaker. Take out 2 pieces of HCG antibody (coating), melt them at room temperature, then add all of them to the coating buffer, and rinse them twice with the coating buffer to ensure that they are completely transferred without residue, and stir evenly. The diluted antibody is the HCG monoclonal antibody, and the concentration of HCG antibody in the coating HCG monoclonal antibody is 2-3μg / ml (preferably 3μg / ml).
[0054] Add HCG monoclonal antibody: Take the diluted HCG antibody solution and use an 8-channel pipette to add it to the prepared 16 blank ELISA plates at 100 μl / well in sequence, with 8 plates in a group, divided into 2 groups in total; after adding each group, check whether there is any omission or excess addition. After confirmation, wrap it with plastic wrap and put it in the refrigerator at 2-8°C overnight (should be at least 8 hours, preferably 8-12 hours).
[0055] Incubation: The next day, take out the ELISA plate that has been kept overnight at 2-8°C and put it into a constant temperature incubator that has been kept at 36-38°C for 1-2 hours. Put 8 pieces in a group, 2 groups in total, put the first group in first, and put the second group in after 30-50 minutes.
[0056] Washing: After the incubation time is up, take out the ELISA plate and wash it with a plate washer, 400μl washing solution / well, wash twice / plate. After washing, turn the ELISA plate upside down on a clean absorbent filter paper, hold the ELISA plate and tap it on the filter paper, tap 2 to 3 times, and observe that there is no residual liquid in the ELISA plate.
[0057] Blocking: Take the prepared blocking solution and use an 8-channel pipette to add 180μl / well to the washed ELISA plate in sequence. 8 plates form a group, and there are 2 groups in total. After adding each group, check it once. After confirming that it is correct, wrap it with plastic wrap and put it in a constant temperature incubator at 36-38℃ for 2-3h.
[0058] Drying: After the incubation time is up, take out the ELISA plate, shake off the blocking solution, and then turn the ELISA plate upside down on a clean absorbent filter paper. Hold the ELISA plate and pat it on the filter paper. Observe that there is no residual liquid in the ELISA plate. Then turn the ELISA plate upside down in a constant temperature incubator, open it in a straight line, and dry it at 36-38℃ for about 2 hours. Observe that there is no visible liquid in the wells of the ELISA plate.
[0059] S103, Packaging and Storage
[0060] Take the dried ELISA plates, and wrap each plate with 2 bags of desiccant in 5 layers of plastic wrap to ensure that the wrapping is tight and airtight. For short-term storage (use within 1 month), place it at 2-8℃; for long-term storage, place it below -10℃, and the validity period is 6 months.
[0061] The chorionic gonadotropin pre-coated ELISA plate prepared by the above preparation method can be prepared in advance, which reduces the analysis time of quantitative detection of HCG in human urine and greatly saves resources. In addition, the chorionic gonadotropin pre-coated ELISA plate can be effectively and stably preserved for a long time and is easy to use.
[0062] In addition, the present application also provides a kit for quantitatively detecting HCG in human urine, which includes the above-mentioned chorionic gonadotropin pre-coated ELISA plate, HRP-labeled HCG antibody, washing solution, color developing solution and stop solution.
[0063] The following is a detailed introduction to the raw materials and preparation methods of various reagents involved in the kit.
[0064] HRP-labeled HCG antibody packaging: Purchase new horseradish peroxidase (HRP)-labeled HCG antibody (ABBEST; Anti-h beta HCG McAb, labeling HRP, Zhengzhou Baierman Biotechnology Co., Ltd., product number 03104700201), melt at room temperature, and package it into 56 μl per tube. After packaging, mark it, store it below -10°C, and use it within the validity period.
[0065] Washing liquid (PBST): Measure 400ml of phosphate buffer solution, 3600ml of purified water, and 4ml of Tween-20 (0.1%), mix and stir evenly, and the solution is ready for immediate use. Phosphate buffer solution (10×PBS): Accurately weigh 14.38g of anhydrous disodium hydrogen phosphate, 79g of sodium chloride, 2g of potassium chloride, and 2.4g of potassium dihydrogen phosphate, add 800ml of purified water, stir until completely dissolved, make up to 1000ml, shake well, and store at room temperature. The shelf life is 1 month.
[0066] Preparation of HCG Standard : Take the product with known potency from the workshop of Shanghai Livzon Biotechnology Co., Ltd. Jiaozuo Branch, dilute it with sample diluent to a solution with HCG potency of 9000-11000mIU / ml (preferably 10000mIU / ml), package it in 0.5ml tubes, mark it after packaging, store it below -10℃, and it is valid for 2 years. Among them, sample diluent: measure 10ml of phosphate buffer mother solution, add 90ml of purified water, weigh 0.2g of BSA (concentration 0.2%) to dissolve, mix it well, and store it in a refrigerator at 2-8℃, and it is valid for 2 days.
[0067] Color development solution:The color developing solution includes 0.4-0.6 ml of substrate solution A, 9.4-9.6 ml of substrate solution B, and 40-45 μl of substrate solution C. As a typical but non-limiting example, accurately measure 0.5 ml of substrate solution A, 9.5 ml of substrate solution B, and 42 μl of substrate solution C, mix them well, and prepare them before use. (Among them, chromogenic substrate A liquid: chromogenic substrate A liquid is a mixed solution of 3,3,5,5-tetramethylbenzidine and anhydrous ethanol, wherein the concentration of 3,3,5,5-tetramethylbenzidine is 1-3 mg / ml. Specifically, 50 mg of TMB powder (3,3,5,5-tetramethylbenzidine, Aike reagent, CAS: 54827-17-7) is dissolved in 25 ml of anhydrous ethanol, mixed and placed in a refrigerator at 2-8°C to obtain chromogenic substrate A liquid, which is valid for 3 months. Chromogenic substrate B liquid: a mixture of anhydrous disodium hydrogen phosphate and citric acid Aqueous solution, the concentration of anhydrous disodium hydrogen phosphate in the color substrate B solution is 7-8g / L, and the concentration of citric acid is 4-6g / L. Specifically, as a typical non-limiting example, take 3.73g of anhydrous disodium hydrogen phosphate, 2.35g of citric acid, add purified water to 500ml, mix well and place in a refrigerator at 2-8°C to prepare color substrate B solution, which is valid for 1 month. Color substrate C solution: It is an aqueous solution with a volume concentration of 25-35% H2O2 and water diluted in a ratio of 1:35-45. Specifically, as a typical non-limiting example: take 1.25ml 30% H2O2, add purified water to 50ml, mix well and place in a refrigerator at 2-8°C to prepare color substrate C solution, which is valid for 3 months).
[0068] Stop Solution : Slowly add 10ml of concentrated sulfuric acid into 80ml of purified water, mix well, and store at room temperature. The shelf life is 3 months.
[0069] The present application also provides a method for quantitatively detecting HCG in human urine, which quantitatively detects HCG in human urine by combining fluorescent magnetic particle enzyme-linked immunosorbent assay and double antibody sandwich enzyme-linked immunosorbent assay.
[0070] Specifically, it includes the following steps:
[0071] Adding HRP-labeled HCG antibody dilution solution to the above chorionic gonadotropin pre-coated ELISA plate;
[0072] The HCG standard solution with different concentrations and the urine sample dilution with different concentrations were added to the chorionic gonadotropin pre-coated ELISA plate for incubation, washing, color development and termination, and then the absorbance value was measured at a dual wavelength of 450nm / 630nm using an ELISA reader;
[0073] Then the reading results are processed: the reading results are sorted from small to large according to the OD value, and 6 urine samples with gradient OD values are selected to detect the immunological titer of HCG by fluorescent magnetic particle enzyme-linked immunosorbent analyzer, and then a standard curve is made with the OD value of the sample as the horizontal axis and the immunological titer as the vertical axis, and the curve equation is calculated;
[0074] The HRP-labeled HCG antibody diluent is prepared by diluting the HRP-labeled HCG antibody solution with the enzyme-labeled antibody diluent at a ratio of 1:1400-1600; and the concentration of the urine sample in the urine sample diluent is 8-12 μl / ml.
[0075] More specifically, the following steps are included:
[0076] S201, Preparation
[0077] At least 30 minutes in advance, take out the HCG ELISA plate, enzyme-labeled antibody diluent, colorimetric substrate A solution, colorimetric substrate B solution, colorimetric substrate C solution, and stop solution required for the test from the refrigerator and place them at room temperature for equilibrium.
[0078] S202, preparing the reagents in the above-mentioned kit.
[0079] S203, prepare HCG standard solution
[0080] Take one piece of the packaged HCG standard (10000mIU / ml) and melt it at room temperature. Take a 10ml centrifuge tube and accurately measure 9.9ml of the sample diluent, add 0.1ml of the HCG standard, shake for 10-30s to mix, and obtain an HCG solution with a titer of 100mIU / ml. Take another 5 1.5ml centrifuge tubes, add HCG solutions with a titer of 100mIU / ml according to the table below, and use the sample diluent to prepare HCG standard solutions with titers of 0mIU / ml, 8-12mIU / ml, 18-22mIU / ml, 38-42mIU / ml, 58-62mIU / ml, and 78-82mIU / ml.
[0081] Standard solution concentration 100mIU / ml HCG solution added Sample diluent addition amount 0mIU / ml 0μl 1000μl 8-12mIU / ml 80-120μl 880-920μl 18-22mIU / ml 180-220μl 780-820μl 38-42mIU / ml 380-420μl 580-620μl 58-62mIU / ml 580-620μl 380-420μl 78-82mIU / ml 780-820μl 180-220μl
[0082] HCG standard solution is used as the external standard of ELISA (also as negative and positive control). After the enzyme labeling is finished, the standard curve is drawn with the OD value of the standard solution as the horizontal axis and the concentration of the standard solution (i.e. the gradient titer of the standard solution) as the vertical axis. The curve equation is calculated. According to the OD value of the standard solution and the R value of the standard curve equation, 2 The value was used to monitor the entire ELISA reaction.
[0083] It should be understood that there are other options for the concentration gradient of the HCG standard solution.
[0084] S204. Diluted urine sample:
[0085] Take a 1.5ml centrifuge tube, add 990μl sample diluent (add 0.2‰ of Dinghao compound food colorant, blue, water-oil dual-purpose pigment, Dongguan Jinjiahe Food Co., Ltd. to the sample diluent in advance), then add 10μl sample, vortex mix to obtain urine sample diluent.
[0086] S205, dilute HRP labeled HCG antibody
[0087] Take 5.5 ml of enzyme-labeled antibody diluent and 3.5 μl of HRP-labeled HCG antibody solution, i.e., dilute at a ratio of about 1:1500, and mix well. Prepare on the day of use, where the enzyme-labeled antibody diluent is purchased from the market, the trade name is: HRP conjugate stabilizer / diluent II, the manufacturer is: Huzhou Yingchuang Biotechnology Co., Ltd., product number: HRP-SD-002.
[0088] S206, add HRP labeled HCG antibody
[0089] Take the ELISA plate that has been equilibrated at room temperature in advance, and add 50 μl of diluted HRP-labeled HCG antibody to each well using an 8-channel gun.
[0090] S207, add urine to dilute sample and standard solution
[0091] Add 0mIU / ml, 8-12mIU / ml, 18-22mIU / ml, 38-42mIU / ml, 58-62mIU / ml, 78-82mIU / ml HCG standard solution, 50μl per well, repeat 2-3 wells for each gradient, then add multiple diluted urine samples (more than 6 urine samples), 50μl per well. Repeat 2-3 wells for each urine sample. After adding samples, put the ELISA plate in a constant temperature incubator at 36-38℃ and incubate for 30 minutes.
[0092] S208, Washing board
[0093] Wash the plate three times using a plate washer according to the operating instructions of the plate washer. Pat the plate dry on absorbent paper for the last wash.
[0094] S209, color rendering
[0095] Add 100 μl of color development solution (freshly prepared and used) to each well and incubate in a constant temperature incubator at 36-38°C for 10-15 minutes.
[0096] S210, Termination
[0097] Add 50 μl of stop solution to each well to terminate the reaction.
[0098] S211, Reading
[0099] Gently shake the ELISA plate with the stop solution added on the desktop to mix it evenly, then put it into the ELISA reader and operate it according to the operating procedures of the ELISA reader. The absorbance value is measured at the dual wavelengths of 450 / 630nm with the ELISA reader.
[0100] S212, Result Conversion
[0101] The results were sorted from small to large according to the OD value, and 6 different urine samples with gradient OD values (refer to the positions of the 6 HCG standard solution points) were selected to detect the HCG immune titer using the Tosoh Corporation's fully automatic fluorescent magnetic particle enzyme-linked immunosorbent analyzer AIA-360. A standard curve was drawn with the OD value of the urine sample as the horizontal axis and the immune titer detected by the AIA-360 fully automatic analyzer as the vertical axis, and the curve equation was calculated.
[0102] When performing immunohistochemistry testing of urine samples, the immunohistochemistry of each urine sample can be calculated by simply substituting the OD value of each urine sample measured according to the above method into the equation.
[0103] The method for quantitatively detecting HCG in human urine provided by the present application combines the fluorescent magnetic microparticle enzyme-linked immunosorbent assay method with the double antibody sandwich enzyme-linked immunosorbent assay method, which solves the problems of being unable to quantify, low sensitivity, poor stability, limited detection range and low repeatability relative to the colloidal gold method; solves the problems of insufficient accuracy and deviation relative to the single enzyme-linked immunosorbent assay; solves the problems of high cost and inability to detect on a large scale relative to the single fluorescent magnetic microparticle enzyme-linked immunosorbent assay and other cutting-edge detection technologies; Based on the above, the method provided by the present application can detect the content of HCG in urine on a large scale, which is fast and low in cost (taking 96 plates as an example, the average cost per well is about 0.434 yuan), with high sensitivity, accuracy and repeatability. The advantages are very obvious. In addition, it is of great significance to many medical and health departments in diagnosing, monitoring and treating various diseases of the human body.
[0104] The features and performance of the present invention are further described in detail below in conjunction with the embodiments.
[0105] Example 1
[0106] S1. Preparation of pre-coated ELISA plate for determination of HCG immunoassay in pregnant urine
[0107] S101, reagent preparation
[0108] HCG coated antibody packaging: After the newly purchased HCG antibody (ABBEST; Anti-h HCG McAb, Zhengzhou Baiman Biotechnology Co., Ltd., product number 031047001) is melted at room temperature, the packaging volume is calculated according to its labeled concentration of 240μg / tube (8 ELISA plates / tube), and the packaging is carried out. After packaging, mark it, store it below -10℃, and use it within the validity period.
[0109] Coating buffer: accurately weigh 1.44 g of anhydrous disodium hydrogen phosphate, 7.9 g of sodium chloride, 0.2 g of potassium chloride, and 0.24 g of potassium dihydrogen phosphate, add 800 ml of purified water, stir until completely dissolved, add 0.5 ml of proclin 300 preservative (Shanjing Biological, product number: ZB116) (concentration 0.05%), make up to 1000 ml, shake well, and store at 2-8°C. The shelf life is 1 month.
[0110] Blocking buffer: accurately weigh 5.75 g of anhydrous disodium hydrogen phosphate and 1.3 g of sodium dihydrogen phosphate dihydrate, add 800 ml of purified water, stir until completely dissolved, add 0.5 ml of proclin 300 preservative (Shanjing Biological, product number: ZB116) (concentration 0.05%), make up to 1000 ml, shake well, and store at 2-8°C. The shelf life is 1 month.
[0111] Blocking solution: Accurately weigh 30 g sucrose (concentration 10%) and 1.5 g BSA (concentration 0.5%), add 300 ml blocking buffer, stir until completely dissolved, and use immediately after preparation.
[0112] Phosphate buffer stock solution (10×PBS): Accurately weigh 14.38 g of anhydrous disodium hydrogen phosphate, 79 g of sodium chloride, 2 g of potassium chloride, and 2.4 g of potassium dihydrogen phosphate, add 800 ml of purified water, stir until completely dissolved, make up to 1000 ml, shake well, and store at room temperature. The shelf life is 3 days.
[0113] Washing solution (PBST): Measure 400 ml of phosphate buffer stock solution, 3600 ml of purified water, and 4 ml of Tween-20 (0.1%), mix and stir evenly, and the solution is ready for use.
[0114] S102, Preparation of pre-coated ELISA plates
[0115] Preparation: Take 16 new ELISA plates (high-absorption transparent ELISA plates, Wuxi Guosheng Bioengineering Co., Ltd., CIH-F8T), mark each one (category, date and number), and keep them for later use;
[0116] Dilute HCG monoclonal antibody: Take 10ml of coating buffer per ELISA plate (16 plates require 160ml in total) and add it to a beaker. Take out 2 pieces of HCG antibody (coating) that have been packaged, melt them at room temperature, then add all of them to the coating buffer, and rinse them with coating buffer twice to ensure that they are completely transferred without residue, and stir evenly. The final concentration of the diluted antibody is 3μg / ml.
[0117] Add HCG monoclonal antibody: Take the diluted HCG antibody solution and add it to the prepared 16 blank ELISA plates in sequence at 100μl / well using an 8-channel pipette. There are 8 plates in a group, divided into 2 groups; after adding each group, check whether there is any omission or over-addition. After confirming that everything is correct, wrap it with plastic wrap and put it in the refrigerator at 2-8℃ overnight (should be at least 8 hours).
[0118] Incubation: The next day, take out the ELISA plate that has been kept overnight at 2-8°C and put it into a constant temperature incubator that has been kept at 36-38°C for 1 hour. Each group of 8 pieces is 2 groups in total. Put the first group first, and then put the second group in after an interval of 40 minutes.
[0119] Washing the plate: After the incubation time is up, take out the ELISA plate and wash it with a plate washer, 400μl washing solution / well, wash twice / plate. After washing, turn the ELISA plate upside down on a clean absorbent filter paper, hold the ELISA plate in your right hand and tap it on the filter paper vigorously, tap 2 to 3 times, and observe that there is no residual liquid in the ELISA plate.
[0120] Blocking: Take the prepared blocking solution and add it to the washed ELISA plate in sequence at 180μl / well using an 8-channel pipette. There are 8 blocks in a group, divided into 2 groups in total. After adding each group, check it once. After confirming that it is correct, wrap it with plastic wrap and put it in a constant temperature incubator at 36-38℃ for 2 hours.
[0121] Drying: After the incubation time is up, take out the ELISA plate, shake off the blocking solution, and then turn the ELISA plate upside down on a clean absorbent filter paper. Hold the ELISA plate and pat it on the filter paper 2 to 3 times. Observe that there is no residual liquid in the ELISA plate. Then turn the ELISA plate upside down in a constant temperature incubator, open it in a straight line, and dry it at 36 to 38 degrees Celsius for about 2 hours. Observe that there is no visible liquid in the wells of the ELISA plate.
[0122] S103, Packaging and Storage
[0123] Take the dried ELISA plates, and wrap each plate with 2 bags of desiccant in 5 layers of plastic wrap to ensure that the wrapping is tight and airtight. For short-term storage (use within 1 month), place it at 2-8℃; for long-term storage, place it below -10℃, and the validity period is 6 months.
[0124] S2. Detection of HCG immunohistochemistry in pregnant urine
[0125] S201, Preparation
[0126] At least 30 minutes in advance, take out the HCG ELISA plate, enzyme-labeled antibody diluent, colorimetric substrate A solution, colorimetric substrate B solution, colorimetric substrate C solution, and stop solution required for the test from the refrigerator and place them at room temperature for equilibrium.
[0127] S202, reagent preparation
[0128] HRP-labeled HCG antibody packaging: Purchase new HCG antibody labeled with HRP (ABBEST; Anti-h beta HCGMcAb, labeling HRP, Zhengzhou Baiman Biotechnology Co., Ltd., product number 03104700201), melt it at room temperature and then package it, mark it, store it below -10°C, and use it within the validity period.
[0129] Phosphate buffer stock solution (10×PBS): Accurately weigh 14.38 g of anhydrous disodium hydrogen phosphate, 79 g of sodium chloride, 2 g of potassium chloride, and 2.4 g of potassium dihydrogen phosphate, add 800 ml of purified water, stir until completely dissolved, make up to 1000 ml, shake well, and store at room temperature. The shelf life is 1 month.
[0130] Washing solution (PBST): Measure 400 ml of phosphate buffer stock solution, 3600 ml of purified water, and 4 ml of Tween-20 (0.1%), mix and stir evenly, and the solution is ready for use.
[0131] Sample diluent: Measure 10 ml of phosphate buffer stock solution, add 90 ml of purified water, weigh 0.2 g of BSA (concentration 0.2%) and dissolve, mix well and store in a refrigerator at 2-8°C. The shelf life is 2 days.
[0132] Preparation of HCG standard: Take a product with known potency from the workshop of Shanghai Livzon Biotechnology Co., Ltd. Jiaozuo Branch, dilute it with sample diluent to a solution with an HCG potency of 10,000 mIU / ml, and package it into 0.5 ml tubes. Mark it after packaging and store it below -10°C. The validity period is 2 years.
[0133] Colorimetric substrate solution A: Dissolve 50 mg of TMB powder (3,3,5,5-tetramethylbenzidine, Aiko reagent, CAS: 54827-17-7) in 25 ml of anhydrous ethanol, mix well and store in a refrigerator at 2-8°C. The shelf life is 3 months.
[0134] Colorimetric substrate solution B: Take 3.73g of anhydrous disodium hydrogen phosphate and 2.35g of citric acid, add purified water to 500ml, mix well and store in a refrigerator at 2-8℃. The shelf life is 1 month.
[0135] Colorimetric substrate solution C: Take 1.25 ml of 30% H2O2, add purified water to 50 ml, mix well and store in a refrigerator at 2-8°C. The shelf life is 3 months.
[0136] Color developing solution: Accurately measure 0.5ml of substrate solution A, 9.5ml of substrate solution B, and 42μl of substrate solution C, mix well, and prepare before use.
[0137] Stop solution: Slowly add 10 ml of concentrated sulfuric acid into 80 ml of purified water, mix well, and store at room temperature. The validity period is 3 months.
[0138] S203, prepare HCG standard solution
[0139] Take one piece of the packaged HCG standard (10000mIU / ml) and melt it at room temperature. Take a 10ml centrifuge tube and accurately measure 9.9ml of the sample diluent, add 0.1ml of the HCG standard, shake for 10-30s to mix, and get a 100mIU / ml HCG solution. Take another 5 1.5ml centrifuge tubes, add 100mIU / ml HCG solution and sample diluent according to the table below to make 0mIU / ml, 10mIU / ml, 20mIU / ml, 40mIU / ml, 60mIU / ml, and 80mIU / ml HCG standard solutions.
[0140] Standard solution concentration 100mIU / ml HCG solution added Sample diluent addition amount 0mIU / ml 0μl 1000μl 10mIU / ml 100μl 900μl 20mIU / ml 200 μl 800μl 40mIU / ml 400μl 600μl 60mIU / ml 600μl 400μl 80mIU / ml 800μl 200 μl
[0141] HCG standard solution was used as the external standard of ELISA (also as negative and positive control). After the enzyme labeling was finished, the standard curve was drawn with the OD value of the standard solution as the horizontal axis and 0mIU / ml, 10mIU / ml, 20mIU / ml, 40mIU / ml, 60mIU / ml, and 80mIU / ml as the vertical axis. The curve equation was calculated. According to the OD value of the standard solution and the R value of the standard curve equation, 2 The value was used to monitor the entire ELISA reaction.
[0142] S204, dilute urine sample:
[0143] Take a 1.5 ml centrifuge tube, add 990 μl of sample diluent (add 0.2‰ of the sample diluent in advance to the top well compound food colorant, blue, water-oil dual-purpose pigment, Dongguan Jinjiahe Food Co., Ltd.), then add 10 μl of sample, and vortex to mix.
[0144] S205, dilute HRP labeled HCG antibody
[0145] Take 5.5 ml of sample diluent and 3.5 μl of HRP-labeled HCG antibody solution, i.e. dilute at a ratio of about 1:1500, and mix well. Prepare on the day of use.
[0146] S206, add HRP labeled HCG antibody
[0147] Take the ELISA plate that has been equilibrated at room temperature in advance, and add 50 μl of diluted HRP-labeled HCG antibody to each well using an 8-channel gun.
[0148] S207, add urine to dilute the sample and standard solution (one-step incubation, HRP-labeled HCG antibody and sample are added to the ELISA plate for incubation at the same time)
[0149] Add 0mIU / ml, 10mIU / ml, 20mIU / ml, 40mIU / ml, 60mIU / ml, 80mIU / ml HCG standard solution to the ELISA plate, 50μl per well, repeat 2 wells for each concentration, then add different diluted urine samples, 50μl per well, repeat 2 wells for each urine sample. After adding samples, place the ELISA plate in a constant temperature incubator at 36-38℃ and incubate for 30 minutes.
[0150] S208, Washing board
[0151] Wash the plate three times using a plate washer according to the operating instructions of the plate washer. Pat the plate dry on absorbent paper for the last wash.
[0152] S209, color rendering
[0153] Add 100 μl of color development solution (freshly prepared and used) to each well and incubate in a constant temperature incubator at 36-38°C for 10-15 minutes.
[0154] S210, Termination
[0155] Add 50 μl of stop solution to each well to terminate the reaction.
[0156] S211, Reading
[0157] Gently shake the ELISA plate with the terminator added on the table to mix it evenly, then put it into the ELISA reader and operate it according to the operating procedures of the ELISA reader. The absorbance value is measured at the dual wavelengths of 450 / 630nm with the ELISA reader.
[0158] S212, Result Conversion
[0159] The results were sorted from small to large according to the OD value, and 6 urine samples with gradient OD values (refer to the positions of 6 HCG standard solution points) were selected to detect HCG immunoassay using Tosoh Corporation's fully automatic fluorescent magnetic particle enzyme-linked immunosorbent analyzer AIA-360. A standard curve was drawn with the OD value of the sample as the horizontal axis and the immunoassay detected by the AIA-360 fully automatic analyzer as the vertical axis, and the curve equation was calculated.
[0160] When performing immunohistochemistry testing of urine samples, the immunohistochemistry of each urine sample can be calculated by simply inserting the OD value of each urine sample measured according to the above method into the equation.
[0161] Example 2
[0162] This embodiment is basically the same as Embodiment 1, except that in Embodiment 1, HRP-labeled HCG antibody and the sample are added to the ELISA plate at the same time and then incubated in one step.
[0163] In this embodiment, a two-step incubation is performed: first, the sample is added, and the ELISA plate is placed in a constant temperature incubator at 36-38°C for incubation for 30 minutes, and then HRP-labeled HCG antibody is added to the ELISA plate, and the ELISA plate is placed in a constant temperature incubator at 36-38°C for incubation for 30 minutes.
[0164] Example 3
[0165] This embodiment is basically the same as Embodiment 1, except that the amounts of chromogenic substrate A solution, chromogenic substrate B solution and chromogenic substrate C solution in the chromogenic solution in this embodiment are different from those in Embodiment 1.
[0166] In this embodiment, the color developing solution includes 0.4 ml of color developing substrate A solution, 9.6 ml of color developing substrate B solution, and 45 μl of color developing substrate C solution;
[0167] Among them, color substrate A solution: take 50mg TMB powder and dissolve it in 50ml anhydrous ethanol, mix well and store it in a refrigerator at 2-8℃. The validity period is 3 months.
[0168] Colorimetric substrate solution B: Take 4g of anhydrous disodium hydrogen phosphate and 6g of citric acid, add purified water to 500ml, mix well and store in a refrigerator at 2-8℃. The shelf life is 1 month.
[0169] Colorimetric substrate solution C: Take 1.35 ml of 30% H2O2, add purified water to 50 ml, mix well and store in a refrigerator at 2-8°C. The shelf life is 3 months.
[0170] Comparative Example 1
[0171] Comparative Example 1 only uses fluorescent magnetic particle enzyme-linked immunosorbent assay for analysis.
[0172] Specifically, the selected urine sample was directly placed in the fully automatic fluorescent magnetic particle enzyme-linked immunosorbent analyzer AIA-360 produced by Tosoh Corporation to directly detect and obtain the HCG immune titer.
[0173] Comparative Example 2
[0174] Comparative Example 2 was analyzed using only the double antibody sandwich ELISA method.
[0175] Specifically: the selected urine sample is operated according to the operating conditions of Example 1 (steps S201-S211), the absorbance value of the urine sample is detected, the absorbance value of the urine sample is substituted into the standard curve obtained in step S203 (with the OD value of the standard solution as the horizontal axis, and the immune titer gradient of the standard solution 0mIU / ml, 10mIU / ml, 20mIU / ml, 40mIU / ml, 60mIU / ml, 80mIU / ml as the vertical axis), and the immune titer of the urine sample is calculated.
[0176] Comparative Example 3
[0177] It is basically the same as Example 1, except that: in Comparative Example 3, the step of "taking out the ELISA plate overnight at 2-8°C and placing it in a constant temperature incubator at 36-38°C and incubating for 1 hour" is omitted, and only the operation of keeping the temperature at 2-8°C overnight is performed.
[0178] Comparative Example 4
[0179] Comparative Example 4 is substantially the same as Example 1, except that the blocking solution in Comparative Example 4 is different from that in Example 1:
[0180] The blocking solution in Comparative Example 4 was: 20% newborn calf serum, 0.01 mol / L PBS solution.
[0181] Comparative Example 5
[0182] Comparative Example 5 is substantially the same as Example 1, except that the coating buffer in Comparative Example 5 is different from that in Example 1:
[0183] The coating buffer in Comparative Example 5 was: pH 9.6 carbonate, 1.59 g of Na2CO3 and 2.93 g of NaHCO3 were weighed respectively, dissolved in deionized water, and then water was added to 1 L.
[0184] 1. Comparative Experimental Analysis
[0185] The analysis methods provided in the above Examples 1-3 and Comparative Examples 1-5 were used to perform 5 parallel experiments on 3 urine samples to determine the immune titers of the 3 urine samples. The results are shown in Table 1. The standard deviation (SD), mean (M), and coefficient of variation (CV) of the 5 parallel results of each experiment are shown in Table 2, where CV = SD / M × 100%:
[0186] Table 1: Immunity titers of samples 1-3 obtained by measuring examples 1-3 and comparative examples 1-5
[0187]
[0188]
[0189] Table 2: Results analysis of Examples 1-3 and Comparative Examples 1-5
[0190]
[0191] Analysis of the results of Examples 1-3 and Comparative Examples 1-5: The CV values of Examples 1-3 and Comparative Examples 1, 2, and 4 are all lower than 5%, indicating that the repeatability of the method is good. The CV values of Comparative Examples 3 and 5 are higher, indicating that the repeatability is poor. From the results shown by the average values (M) of Examples 1-3 and Comparative Example 1, it can be seen that the immune titer obtained in Examples 1-3 is almost the same as that in Comparative Example 1, indicating that the method results of the present application are accurate. Since the method provided in the present application only needs to use the fully automatic fluorescent magnetic particle enzyme-linked immunosorbent analyzer AIA-360 of Tosoh Corporation to detect the immune titer of 6 urine samples, the absorbance of subsequent urine samples is directly measured, and the immune titer of the urine sample can be obtained by the standard curve of step S121, for 96 For the 96-well ELISA plate, compared with using Tosoh Corporation's fully automatic fluorescent magnetic particle enzyme-linked immunosorbent assay (ELISA) AIA-360 to detect the immune titer of all urine samples, the method of the present application is about 42 times cheaper than that of comparative example 1 (specifically, taking 96 plates as an example, the average cost per well is about 0.434 yuan). The detection results of comparative example 2 have a larger error compared with those of comparative example 1, indicating that the results of the double antibody sandwich ELISA method alone are unstable; the results of comparative example 3 have a larger error compared with those of comparative example 1, indicating that only performing the operation at a temperature of 2 to 8°C and overnight will lead to incomplete incubation, and the quality of the prepared chorionic gonadotropin pre-coated ELISA plate product is poor, which affects the subsequent analysis and has poor repeatability. The results of Comparative Example 4 are almost consistent with those of Comparative Example 1 and the CV value is lower, but when bovine serum albumin is selected as the blocking liquid in Example 1, its cost is about 0.26 yuan / 96 wells, and when newborn calf serum is selected as the blocking liquid in Comparative Example 4, its cost is about 7 yuan / 96 wells. It can be seen that the newborn calf serum used for coating in Comparative Example 4 increases the detection cost, and the liquid newborn calf serum is easy to grow bacteria after opening, and is not as easy to preserve as bovine albumin; the experimental results of Comparative Example 5 are quite different from those of Comparative Example 1, and the CV value is higher and the repeatability is poor, indicating that the coating buffer selected in Example 1 of the present application can improve the accuracy of the results.
[0192] 2. Stability Experiment Analysis
[0193] The chorionic gonadotropin pre-coated ELISA plate prepared in Example 1 was stored in a -10°C refrigerator, and the stability of the ELISA plate was tested at 7 days, 14 days, 30 days, 60 days, 120 days, and 180 days. Please refer to Table 3 for the test results.
[0194] Table 3: Stability test results
[0195]
[0196] Analysis of stability test results: After the chorionic gonadotropin pre-coated ELISA plate was stored at -10℃ for 180 days, the OD values of the standards did not decrease significantly, and R 2 The value is ≥0.99, indicating that the chorionic gonadotropin pre-coated ELISA plate prepared by the preparation method of the chorionic gonadotropin pre-coated ELISA plate provided in the present application has good stability.
[0197] In summary, the preparation method of the chorionic gonadotropin pre-coated ELISA plate provided by the present application can prepare a chorionic gonadotropin pre-coated ELISA plate with a long shelf life and stable product, and a large number of chorionic gonadotropin pre-coated ELISA plates are prepared at one time, which is convenient for subsequent experiments and detection, greatly saving time and operating costs, and improving analysis efficiency. Further, the method for quantitative detection of HCG in human urine provided by the present application combines the fluorescent magnetic particle enzyme-linked immunosorbent assay method and the double antibody sandwich enzyme-linked immunosorbent assay method, which solves the problems of inability to quantify, low sensitivity, poor stability, limited detection range and low repeatability relative to the colloidal gold method; solves the problem of insufficient accuracy and deviation relative to the single enzyme-linked immunosorbent assay; solves the problem of high cost and inability to detect on a large scale relative to the single fluorescent magnetic particle enzyme-linked immunosorbent assay and other cutting-edge detection technologies; Based on the above, the method provided by the present application can detect the content of HCG in urine on a large scale, which is fast and low cost (taking 96 plates as an example, the average cost per well is about 0.434 yuan), with high sensitivity, accuracy and repeatability. The advantages are obvious. In addition, it is of great significance to many medical and health departments in diagnosing, monitoring and treating various diseases of the human body. The kit for quantitatively detecting HCG in human urine provided by the present application comprises various reagents involved in the method of the present application, thereby simplifying the quantitative detection of HCG in human urine.
[0198] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A method for preparing a chorionic gonadotropin pre-coated ELISA plate, characterized in that: It includes: The ELISA plate with HCG monoclonal antibody was incubated at 2-8°C for 8-12 hours, and then incubated at 36-38°C for 1-2 hours. The ELISA plate was then washed with a washing solution, and a blocking solution was added for blocking and incubated at 36-38°C for 1-2 hours. The blocking solution in the ELISA plate was then removed. The concentration of HCG antibody in the HCG monoclonal antibody is 2-3 μg / ml; the HCG monoclonal antibody is obtained by diluting the HCG antibody with a coating buffer; the coating buffer is a mixed aqueous solution containing anhydrous disodium hydrogen phosphate, sodium chloride, potassium chloride, potassium dihydrogen phosphate and a preservative; and the blocking solution is prepared by mixing sucrose, bovine serum albumin and the blocking buffer.
2. The method for preparing the chorionic gonadotropin pre-coated ELISA plate according to claim 1, characterized in that: The concentration of anhydrous disodium hydrogen phosphate in the coating buffer is 1-2 g / L, the concentration of sodium chloride is 7.5-8.5 g / L, the concentration of potassium chloride is 0.1-0.3 g / L, the concentration of potassium dihydrogen phosphate is 0.2-0.3 g / L and the concentration of the preservative is 0.4-0.6 ml / L.
3. The method for preparing the chorionic gonadotropin pre-coated ELISA plate according to claim 1, characterized in that: The concentration of sucrose in the blocking solution is 8-12 g / ml, and the concentration of bovine serum albumin is 0.4-0.6 g / ml; the blocking buffer is a mixed aqueous solution of anhydrous disodium hydrogen phosphate, dihydrate sodium dihydrogen phosphate and a preservative, wherein the concentration of anhydrous disodium hydrogen phosphate in the blocking buffer is 5-6 g / L, the concentration of dihydrate sodium dihydrogen phosphate is 1-2 g / L, and the concentration of the preservative is 0.4-0.6 ml / L.
4. The method for preparing the chorionic gonadotropin pre-coated ELISA plate according to claim 1, characterized in that: The step of removing the blocking solution from the ELISA plate comprises: firstly turning the ELISA plate upside down to allow the blocking solution to be discharged, and then drying the ELISA plate at 36-38° C. for 2-3 hours.
5. The method for preparing the chorionic gonadotropin pre-coated ELISA plate according to claim 4, characterized in that: After the ELISA plate is dried, the method further includes packaging and storing the ELISA plate: each dried ELISA plate and 2-3 bags of desiccant are wrapped with 4-6 layers of plastic wrap, and then stored at 2-8°C for 1 month or below -10°C for 6 months.
6. A chorionic gonadotropin pre-coated ELISA plate, characterized in that: The plate is prepared by the method for preparing the chorionic gonadotropin pre-coated ELISA plate according to any one of claims 1 to 5.
7. Use of the chorionic gonadotropin pre-coated ELISA plate as claimed in claim 6 in the preparation of a kit for quantitatively detecting HCG in human urine.
8. A kit for quantitatively detecting HCG in human urine, characterized in that: It includes: The chorionic gonadotropin pre-coated ELISA plate as claimed in claim 6.
9. The kit for quantitatively detecting HCG in human urine according to claim 8, characterized in that: The kit also includes HRP-labeled HCG antibody, HCG standard, washing solution, color developing solution and stop solution.
